| Arvid Carlsson: an early pioneer in translational medicine. | |
| | |
MedLine Citation:
|
PMID: 20368162 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Translational medicine has recently experienced an upsurge in interest and funding, yet the idea is not new. More than half a century ago, the Swedish scientist Arvid Carlsson performed basic research on the neurotransmitter dopamine that was rapidly translated into the first clinical treatment for Parkinson 's disease. For his contributions, Carlsson shared the Nobel Prize in Physiology or Medicine in the year 2000. |
| | |
Authors:
|
Julie K Andersen |
Publication Detail:
|
Type: Biography; Historical Article; Journal Article |
Journal Detail:
|
Title: Science translational medicine Volume: 1 ISSN: 1946-6242 ISO Abbreviation: Sci Transl Med Publication Date: 2009 Oct |
Date Detail:
|
Created Date: 2010-04-06 Completed Date: 2010-07-12 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101505086 Medline TA: Sci Transl Med Country: United States |
Other Details:
|
Languages: eng Pagination: 2ps3 Citation Subset: IM |
Affiliation:
|
Buck Institute for Research in Aging, Novato, CA 94949, USA. Andersen@buckinstitute.org |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Biomedical Research* History, 20th Century History, 21st Century Humans Nobel Prize Parkinson Disease / therapy Sweden |
| Personal Name Subject | |
Personal Name Subject:
|
Arvid Carlsson |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Gene therapy for dopamine replacement in Parkinson's disease.
Next Document: Dopamine gene therapy for Parkinson's disease in a nonhuman primate without associated dyskinesia.